Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion. - Pellagatti, A; Jadersten, M; Forsblom, A; Cattan, H; Christensson, B; Emanuelsson, E; Merup, M; Nilsson, L; Samuelsson, J; Sander, B; Wainscoat, J; Boultwood, J; et al. (2006)